- Home
- UCTT vs TRVI Comparison
UCTT vs TRVI Comparison
Compare UCTT & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UCTT
- TRVI
- Stock Information
- Founded
- UCTT 1991
- TRVI 2011
- Country
- UCTT United States
- TRVI United States
- Employees
- UCTT N/A
- TRVI N/A
- Industry
- UCTT Semiconductors
- TRVI Biotechnology: Pharmaceutical Preparations
- Sector
- UCTT Technology
- TRVI Health Care
- Exchange
- UCTT Nasdaq
- TRVI Nasdaq
- Market Cap
- UCTT 1.2B
- TRVI 1.1B
- IPO Year
- UCTT 2004
- TRVI 2019
- Fundamental
- Price
- UCTT $28.75
- TRVI $10.37
- Analyst Decision
- UCTT Strong Buy
- TRVI Strong Buy
- Analyst Count
- UCTT 3
- TRVI 9
- Target Price
- UCTT $39.00
- TRVI $20.72
- AVG Volume (30 Days)
- UCTT 416.6K
- TRVI 1.7M
- Earning Date
- UCTT 10-28-2025
- TRVI 11-05-2025
- Dividend Yield
- UCTT N/A
- TRVI N/A
- EPS Growth
- UCTT N/A
- TRVI N/A
- EPS
- UCTT N/A
- TRVI N/A
- Revenue
- UCTT $2,141,100,000.00
- TRVI N/A
- Revenue This Year
- UCTT N/A
- TRVI N/A
- Revenue Next Year
- UCTT $4.45
- TRVI N/A
- P/E Ratio
- UCTT N/A
- TRVI N/A
- Revenue Growth
- UCTT 14.28
- TRVI N/A
- 52 Week Low
- UCTT $16.66
- TRVI $2.36
- 52 Week High
- UCTT $40.64
- TRVI $11.11
- Technical
- Relative Strength Index (RSI)
- UCTT 55.85
- TRVI 68.47
- Support Level
- UCTT $25.56
- TRVI $9.29
- Resistance Level
- UCTT $30.41
- TRVI $11.11
- Average True Range (ATR)
- UCTT 1.49
- TRVI 0.56
- MACD
- UCTT -0.06
- TRVI 0.06
- Stochastic Oscillator
- UCTT 62.05
- TRVI 75.73
About UCTT Ultra Clean Holdings Inc.
Ultra Clean Holdings Inc, through its subsidiaries, manufactures and supplies production tools, modules, and subsystems for the semiconductor capital equipment industry. The product includes precision robotic solutions, gas delivery systems, and a variety of industrial and automation production equipment products; subsystems include wafer cleaning subsystems, chemical delivery modules, top-plate assemblies, frame assemblies, and process modules. Its customer base includes firms in the semiconductor capital equipment industry, medical, energy, industrial, flat panel, and research equipment industries. It has two segments Products and Services. Its principal markets are Americas, Asia Pacific and EMEA.
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.